Penggunaan Insulin dan Gliquidon pada Pasien Komplikasi Nefropati Diabetik Salah Satu Rumah Sakit di Lampung Tahun 2020

Nia Fernanda, Gusti Ayu Rai Saputri, Ade Maria Ulfa


Background: Diabetic Nephropathy (DN) is major complication of diabetes mellitus (DM) which still become major health problem in Indonesia because the complications are short-term and long-term rational treatment requires patients with diabetes mellitus (DM) diabetic nephropathy (ND) complications to obtain treatment that suits the patient's circumstances and conditions which can be monitored with the 6T 1W indicator. Objective: To evaluate the rationality of antidiabetic prescription in DN outpatient from RS P Lampung. Methods: The design of this study was descriptive analytic to get the profil of the rational use of antidiabetic drugs. 49 participants were selected using inclusion and exclusion criteria. This study is non experimental which is analyzed descriptively by purposive sampling method. Restrospective data retrieval of the patient's medical records. The results of the study were compared to the (AAFP) American of Family Physicians, 2007 standard. Results: 95% of respondent diagnosed DN correctly based on the guideline. 58,1% of participants treated with insulin, whereas 39,2% got sulfonylurea. the antidiabetic drugs for ND outpatient in RS P Lampung were rationally prescribed based on the accurate diagnosis, appropriate medication, appropriate patients, precise timing of administration, appropriate way of administration and dose, and the alertness of side effects. Conclusion: The rational antidiabetic drugs for ND outpatient has been implemented in RS P Lampung.

Full Text:



Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes care. 2010 Aug 1;33(8):1895-902.

Karamat MA, Syed A, Hanif W. Review of diabetes management and guidelines during Ramadan. Journal of the Royal Society of Medicine. 2010 Apr 1;103(4):139-47.

Elmehdawi. 2009. Incidence of diabetic ketoacidosis during ramadhan fasting in benghazi Libya. OMJ. 24 99-102

Salti I, Be´nard E, Detournay B, Bianchi- Biscay M, Le Brigand C, Voinet C, Jabbar A, EPIDIAR study group. A populationbased study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27:2306–2311

Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes (Review). Diabetes Care. 2003;26:1902–1912

Felig P. Starvation In Endocrinology. DeGroot LJ, Ed. New York, Grune & Stratton. 1979, p. 1927–1940

Cahill GF Jr. Starvation in man. N Engl J Med. 1970;282:668–675

Reiter J, Wexler ID, Shehadeh N, Tzur A, Zangen D. Type 1 diabetes and prolonged fasting. Diabet Med, 2007;24:436–439

Halberg N, Henriksen M, So¨derhamn N, Stallknecht B, Ploug T, Schjerling P, Dela

F. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol 2005;99:2128– 2136

Varady KA, Hellerstein MK. Alternateday fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr 2007;86:7–13

Uysal AR, Erdog˘an MF, Sahin G, Kamel N, Erdog˘an G. Clinical and metabolic effects of fastingin 41 type 2 diabetic patients during Ramadan (Letter). Diabetes Care 1998;21:2033– 2034

Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulintreated diabetes mellitus. Diabet Med. 1999;16:466 – 471

Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes. Arch Int Med 2001;161:1653– 1659

Hassanein, M., et al., Diabetes and Ramadan: practical guidelines International Diabetes Federation (IDF) in collaboration with the Diabetes and Ramadan (DAR) International Alliance. 2016.

Babineaux, S.M., et al., Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med, 2015. 32(6): p. 819-28.

Beshyah, W.S. and S.A. Beshyah, Bibliometric analysis of the literature on Ramadan fasting and diabetes in the past three decades (1989–2018). Diabetes research and clinical practice, 2019. 151: p. 313-322.

Salti, I., et al., A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care, 2004. 27(10): p. 2306-11.



  • There are currently no refbacks.


Editorial Office:

Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 85259506000, Faximile (+62) 341 558933

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.